天体细胞 miR-129-5p 在前性痴呆症中的作用
Lalit Kaurani1,2, Ranjit Pradhan3, Sophie Schröder3
1Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. lalit.kaurani@dzne.de.
Translational psychiatry
|April 11, 2025
概括
前性痴呆症 (FTD) 研究显示,miR-129-5p在FTD大脑中受到放松. 它在星球细胞中的损失会导致神经炎症,并损害神经元的支持,这表明它是一个治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 前性痴呆 (FTD) 是一种进展性神经退行性疾病,由于前和叶退化,影响行为,语言和认知.
- 遗传突变 (GRN,MAPT,C9ORF72) 是FTD病变发生的关键驱动因素.
研究的目的:
- 为了研究微RNAs在FTD病变发生中的作用.
- 通过不同突变类型,识别FTD脑组织中放松调节的特定微RNA.
主要方法:
- 在FTD患者的死后额头和脑组织上进行小RNA测序.
- 在体外功能测试使用星球细胞和神经元细胞模型.
主要成果:
- 在FTD大脑中,miR-129-5p在不论突变类型或大脑区域,都得到了持续的放松.
- 星球细胞中miR-129-5p的丧失导致神经炎症和谷氨酸吸收受损.
- 星球细胞中miR-129-5p的耗尽导致神经元脊柱损失和网络活动的改变.
结论:
- miR-129-5p对天体细胞功能和神经元健康起着至关重要的作用.
- 天体细胞通过涉及miR-129-5p的机制与FTD病原发生有关.
- miR-129-5p是FTD和相关的神经退行性疾病的潜在治疗标.
更多相关视频
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.1K
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
Published on: June 10, 2021
4.8K
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
